NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-121919

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedProphylaxis of new type of influenza infection
Date of first enrollment22/8/2012
Target sample size600
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : KIB-PCI Dosage And administration of the intervention : intramuscular Control intervention name : null

Outcome(s)

Primary OutcomeSRH antibody titer against H5 antigen
Secondary OutcomeHI antibody titer against H5 antigen Neutralizing antibody titer against H5N1 influenza virus

Key inclusion & exclusion criteria

Age minimum20
Age maximum64
GenderBOTH
Include criteriahealthy adult Japanese volunteers
Exclude criteria1)Subjects with history of H5N1 influenza 2)Subjects with history of H5N1 influenza vaccination

Related Information

Contact

public contact
Name DAIICHI SANKYO Co.,Ltd. Contact for Clinical Trial Information
Address http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation